Loading company…
PIC Therapeutics, Inc. of Natick, US is a biotechnology company developing cancer treatments that target the Pre-Initiation Complex.
PIC Therapeutics, Inc., founded in 2016 and based in Natick, US, develops cancer therapeutics that modulate RNA translation by targeting the Pre-Initiation Complex, aiming to block the production of cancer-driving proteins. The company's treatments are aimed at patients with therapy-resistant or complex tumors. Its Series A round closed on October 7, 2022, raising USD 6.47 mn led by OrbiMed Advisors. The current CEO is Katherine Bowdish.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in